There have been 50 recent insider transactions recorded for POINT Biopharma Global Inc. (PNT), including 25 buys and 21 sells. Total insider buying was valued at $14.9M and total insider selling at $70.58M.
Notable insiders with recent activity include Silber Allan C, Lubner David Charles, Malik Rajesh. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — PNT
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2023-12-27 |
Silber Allan C |
Executive Chairman |
Return of Shares |
537,322 |
$6.78 |
$3.64M |
- |
| 2023-12-27 |
Lubner David Charles |
Director |
Return of Shares |
44,749 |
$9.12 |
$408.11K |
- |
| 2023-12-27 |
Malik Rajesh |
Director |
Return of Shares |
44,749 |
$9.12 |
$408.11K |
- |
| 2023-12-27 |
Fleshner Neil E. |
Chief Medical Officer |
Return of Shares |
84,257 |
$6.78 |
$571.26K |
- |
| 2023-12-27 |
Demers William L. |
Chief Financial Officer |
Return of Shares |
131,355 |
$6.78 |
$890.59K |
- |
| 2023-12-27 |
Goodman Jonathan R. |
Director |
Return of Shares |
44,749 |
$9.12 |
$408.11K |
- |
| 2023-12-27 |
Margolin Yael |
Director |
Return of Shares |
44,749 |
$9.12 |
$408.11K |
- |
| 2023-12-27 |
Mccann Joe A. |
Chief Executive Officer |
Return of Shares |
692,643 |
$6.78 |
$4.7M |
- |
| 2023-12-27 |
Hogue Gerald L. |
Director |
Return of Shares |
44,749 |
$9.12 |
$408.11K |
- |
| 2023-12-27 |
Jensen Jessica D. |
EVP Clinical Development |
Return of Shares |
136,055 |
$6.78 |
$922.45K |
- |
| 2023-12-27 |
Kelly Justyna |
Chief Operating Officer |
Return of Shares |
98,358 |
$6.78 |
$666.87K |
- |
| 2023-12-26 |
Lubner David Charles |
Director |
Tender Offer (Sell) |
35,400 |
$12.50 |
$442.5K |
3,600 |
| 2023-12-26 |
Malik Rajesh |
Director |
Tender Offer (Sell) |
3,700 |
$12.50 |
$46.25K |
- |
| 2023-12-26 |
Goodman Jonathan R. |
Director |
Tender Offer (Sell) |
41,872 |
$12.50 |
$523.4K |
- |
| 2023-12-26 |
Hogue Gerald L. |
Director |
Tender Offer (Sell) |
21,596 |
$12.50 |
$269.95K |
- |
| 2023-12-22 |
Silber Allan C |
Executive Chairman |
Tender Offer (Sell) |
71,744 |
$12.50 |
$896.8K |
- |
| 2023-12-22 |
Fleshner Neil E. |
Chief Medical Officer |
Tender Offer (Sell) |
358 |
$12.50 |
$4.48K |
- |
| 2023-12-22 |
Mccann Joe A. |
Chief Executive Officer |
Tender Offer (Sell) |
3,494,153 |
$12.50 |
$43.68M |
- |
| 2023-12-18 |
Bvf Partners L P/il |
Officer |
Informative Sell |
896,366 |
$12.45 |
$11.16M |
- |
| 2023-11-06 |
Mccann Joe A. |
Chief Executive Officer |
Gift (Given) |
120,000 |
- |
- |
3,494,153 |
| 2023-11-03 |
Silber Allan C |
Executive Chairman |
Gift (Given) |
500,000 |
- |
- |
38,087 |
| 2023-11-02 |
Bvf Partners L P/il |
10 Percent Owner |
Disposition |
- |
- |
- |
896,366 |
| 2023-10-31 |
Fleshner Neil E. |
Chief Medical Officer |
Gift (Given) |
250,000 |
- |
- |
2,773,045 |
| 2023-06-13 |
Martell Bridget A |
Director |
RSU Award |
80,503 |
$10.08 |
$811.47K |
80,503 |
| 2023-06-12 |
Martell Bridget A |
Director |
Unknown |
- |
- |
- |
- |
| 2023-06-01 |
Lubner David Charles |
Director |
RSU Award |
44,749 |
$9.12 |
$408.11K |
44,749 |
| 2023-06-01 |
Malik Rajesh |
Director |
RSU Award |
44,749 |
$9.12 |
$408.11K |
44,749 |
| 2023-06-01 |
Goodman Jonathan R. |
Director |
RSU Award |
44,749 |
$9.12 |
$408.11K |
44,749 |
| 2023-06-01 |
Margolin Yael |
Director |
RSU Award |
44,749 |
$9.12 |
$408.11K |
44,749 |
| 2023-06-01 |
Hogue Gerald L. |
Director |
RSU Award |
44,749 |
$9.12 |
$408.11K |
44,749 |
| 2023-03-28 |
Silber Allan C |
10 Percent Owner, Officer: Executive Chairman |
RSU Award |
537,322 |
$6.78 |
$3.64M |
537,322 |
| 2023-03-28 |
Fleshner Neil E. |
Chief Medical Officer |
RSU Award |
84,257 |
$6.78 |
$571.26K |
84,257 |
| 2023-03-28 |
Demers William L. |
Chief Financial Officer |
RSU Award |
131,355 |
$6.78 |
$890.59K |
131,355 |
| 2023-03-28 |
Mccann Joe A. |
Chief Executive Officer |
RSU Award |
692,643 |
$6.78 |
$4.7M |
692,643 |
| 2023-03-28 |
Jensen Jessica D. |
EVP Clinical Development |
RSU Award |
136,055 |
$6.78 |
$922.45K |
136,055 |
| 2023-03-28 |
Kelly Justyna |
Chief Operating Officer |
RSU Award |
98,358 |
$6.78 |
$666.87K |
98,358 |
| 2023-03-21 |
Hogue Gerald L. |
Director |
Option Exercise (Sell) |
17,936 |
$6.97 |
$125.01K |
17,936 |
| 2022-11-29 |
Mccann Joe A. |
Chief Executive Officer |
Informative Buy |
2,160 |
$6.64 |
$14.34K |
3,616,313 |
| 2022-11-28 |
Malik Rajesh |
Director |
Informative Buy |
3,700 |
$6.66 |
$24.64K |
3,700 |
| 2022-11-25 |
Hogue Gerald L. |
Director |
Informative Buy |
3,660 |
$6.82 |
$24.94K |
3,660 |
| 2022-11-23 |
Lubner David Charles |
Director |
Informative Buy |
3,600 |
$6.85 |
$24.66K |
3,600 |
| 2022-11-21 |
Margolin Yael |
Director |
Informative Buy |
1,710 |
$6.56 |
$11.22K |
1,710 |
| 2022-11-18 |
Silber Allan C |
Executive Chairman |
Informative Buy |
22,397 |
$6.50 |
$145.58K |
4,268,605 |
| 2022-11-18 |
Goodman Jonathan R. |
Director |
Informative Buy |
6,000 |
$6.33 |
$37.98K |
41,872 |
| 2022-11-17 |
Silber Allan C |
Executive Chairman |
Informative Buy |
27,603 |
$6.00 |
$165.62K |
4,246,208 |
| 2022-06-02 |
Lubner David Charles |
Director |
RSU Award |
25,614 |
$8.31 |
$212.85K |
25,614 |
| 2022-06-02 |
Malik Rajesh |
Director |
RSU Award |
25,614 |
- |
- |
25,614 |
| 2022-06-02 |
Goodman Jonathan R. |
Director |
RSU Award |
25,614 |
- |
- |
25,614 |
| 2022-06-02 |
Margolin Yael |
Director |
RSU Award |
25,614 |
- |
- |
25,614 |
| 2022-06-02 |
Hogue Gerald L. |
Director |
RSU Award |
25,614 |
- |
- |
25,614 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
